12 February 2015
In what is believed to be the largest epigenetic analysis to date of cell-signaling molecules in early-stage melanoma, researchers have identified two tiny bits of non-coding genetic material in primary tumors that appear critical to stalling the cancer’s spread — and essentially setting the biological fate of the disease.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/ro90ZYjfTzI/150212102712.htm
